Borst P
The Netherlands Cancer Institute, Amsterdam.
Acta Oncol. 1991;30(1):87-105. doi: 10.3109/02841869109091819.
An overview of our present understanding of mechanisms of resistance against cytotoxic drugs is presented. Most of this understanding has come from studies on tumor cells made resistant in vitro, but there is reason to think that similar mechanisms are responsible for resistance in patients. After a brief overview of biochemical mechanisms of drug resistance, the types of mutations in tumor cells that can alter drug handling are discussed. Three examples of resistance are analysed in more detail: resistance to the folate analogue methotrexate; the multidrug resistance caused by increased levels of P-glycoprotein, which extrudes drugs from the cell; and resistance to alkylating agents.
本文概述了我们目前对细胞毒性药物耐药机制的理解。大部分理解来自对体外诱导产生耐药性的肿瘤细胞的研究,但有理由认为患者体内的耐药性也是由类似机制引起的。在简要概述耐药性的生化机制之后,讨论了肿瘤细胞中可改变药物处理方式的突变类型。更详细地分析了三种耐药性实例:对叶酸类似物甲氨蝶呤的耐药性;由P-糖蛋白水平升高导致的多药耐药性,P-糖蛋白可将药物排出细胞;以及对烷化剂的耐药性。